← FDA Drug Approvals (Drugs@FDA)
EVRYSDI
NDA · New Drug Application · Sponsor: GENENTECH INC · Approved 2025-02-11
Drug application
- FDA Application #
NDA219285- Application type
- New Drug Application
- Brand name
- EVRYSDI
- Generic name
- RISDIPLAM
- Active ingredients
- RISDIPLAM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- GENENTECH INC
- Manufacturer
- Genentech, Inc.
- First approval
- 2025-02-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown